Literature DB >> 25128310

Two different treatment options for intramuscular plantar hemangioma: surgery versus percutaneous sclerotherapy.

Mustafa Uslu1, Halit Beşir2, Hakan Turan3, Halil Bozkaya4, Havva Erdem5.   

Abstract

Intramuscular hemangiomas are benign neoplasms usually seen in children and adolescents. They tend to occur in the deep fascia and muscle and more often in the lower extremity, although they are rarely encountered in the plantar musculature. Surgical excision, ultrasound- or fluoroscopic-guided percutaneous sclerotherapy, and angiographic embolization are all treatment options. Surgical excision is the most prevalent form of therapy, although this can be difficult in the hands and feet. For this reason, ultrasound- and fluoroscopic-guided percutaneous sclerotherapy is a useful treatment option for pedal intramuscular hemangioma. In the present report, we describe 2 cases of intramuscular hemangioma in children, 1 treated by excision and 1 by percutaneous sclerosis.
Copyright © 2014 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  benign vascular neoplasm; capillary; excision; fluoroscopy; foot; magnetic resonance image

Mesh:

Substances:

Year:  2014        PMID: 25128310     DOI: 10.1053/j.jfas.2014.06.008

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  3 in total

1.  Aggressive intramuscular hemangiomas in the upper extremity: A case report.

Authors:  Hui Lu; Qiang Chen; Hu Yang; Hui Shen
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

2.  Surgical management of intramuscular hemangioma of the foot: a case report.

Authors:  K Lahrach; S Abdulrazak; A Marzouki; F Boutayeb
Journal:  Patient Saf Surg       Date:  2019-03-26

3.  Intramuscular hemangioma within the biceps brachii causing the limitations of elbow extension and forearm pronation: A case report.

Authors:  Yang Liu; Ruijun Li; Zhigang Liu; Shuang Wang; Laijin Lu
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.